Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$0 Buy
36
+26
+260% +$145 ﹤0.01% 2833
2026
Q1
$0 Hold
10
﹤0.01% 2754
2025
Q4
$0 Sell
10
-1
-9% -$5 ﹤0.01% 2724
2025
Q3
$0 Hold
11
﹤0.01% 2759
2025
Q2
$0 Hold
11
﹤0.01% 2744
2025
Q1
$0 Hold
11
﹤0.01% 2715
2024
Q4
$0 Buy
11
+7
+175% +$54 ﹤0.01% 2727
2024
Q3
$0 Hold
4
﹤0.01% 2751
2024
Q2
$0 Sell
4
-86
-96% -$932 ﹤0.01% 2739
2024
Q1
$1K Sell
90
-674
-88% -$8.71K ﹤0.01% 2117
2023
Q4
$11K Buy
764
+658
+621% +$9.2K 0.01% 1518
2023
Q3
$2K Buy
106
+2
+2% +$31 ﹤0.01% 1851
2023
Q2
$2K Sell
104
-127
-55% -$2.15K ﹤0.01% 1871
2023
Q1
$4K Buy
231
+84
+57% +$1.57K ﹤0.01% 1629
2022
Q4
$3K Sell
147
-82
-36% -$1.66K ﹤0.01% 1723
2022
Q3
$4K Buy
229
+75
+49% +$1.52K ﹤0.01% 1580
2022
Q2
$3K Sell
154
-24
-13% -$563 ﹤0.01% 1557
2022
Q1
$5K Buy
178
+46
+35% +$1.26K ﹤0.01% 1509
2021
Q4
$4K Buy
+132
New +$3.73K 0.01% 1423

Other funds holding TBI

Covestor's TBI Position: Q2 2026 in Review

Covestor increased its Trueblue (TBI) stake by 260% in Q2 2026, buying an estimated $145 and bringing the position to 36 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2833.

Covestor first reported a position in TBI in Q4 2021 and has held it in 19 quarters since. The position peaked at $11K in Q4 2023. 113 funds tracked by Wall St. Rank hold TBI as of Q2 2026.

  • Covestor held 36 shares of Trueblue worth $0 as of Q2 2026.
  • Covestor bought 26 Trueblue shares in Q2 2026, an estimated $145.
  • Trueblue made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #2833 holding.
  • Covestor first reported a position in Trueblue in Q4 2021 and has held it in 19 quarters since.
  • Covestor's Trueblue position peaked at $11K in Q4 2023.
  • 113 funds tracked by Wall St. Rank held Trueblue as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.